Stocks / NASDAQ / InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings Corp.

Industry:   Health Care - Medical/Dental Instruments Stock Symbol:   NVIV - NASDAQ Animal Usage:   Animal Testing

Our Opinion

InVivo Therapeutics Holdings Corp. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“In the data to be presented at Neuroscience 2016, we examine findings regarding spinal cord preservation, neural regeneration and remyelination in animal models of spinal cord injury, contributing to the growing body of spinal cord injury research.” Read the following article

Company Description

Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which focuses on the treatment of spinal cord injuries. Its treatment approach is the Neuro-Spinal Scaffold implant, which is designed for implantation at the site of injury within a spinal cord and is intended to treat acute SCI. The company was founded by Joseph P. Vacanti, Frank M. Reynolds and Robert Langer on November 28, 2005 and is headquartered in Cambridge, MA. [Source: MarketWatch]

Company Website: www.invivotherapeutics.com

Contact:   https://www.invivotherapeutics.com/home/contact; IR: IR@invivotherapeutics.com;